Fig. 2.

Enhanced antitumor activity of PTX formulated in PEG_5K-VE₂ micelles. BALB/c mice were inoculated s.c. with 4T1.2 cells (2 × 10⁵ cells/mouse). Five days later, mice received various treatments on days 1, 3, 5, 9, 12, and tumor growth was monitored and plotted as relative tumor volume (mm³). P < 0.02 (PEG_5K-VE₂/PTX vs. Taxol, PEG_2K-VE/PTX or PEG_2K-VE₂/PTX). N = 5. Taken with permission from (80)